Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Apoptosis

Enhanced ability of daniplestim and myelopoietin-1 to suppress apoptosis in human hematopoietic cells

Abstract

Modified and chimeric cytokines have been developed to aid in the recovery of hematopoietic precursor cells after myeloablative chemotherapy. The interleukin-3 (IL-3) receptor agonist, daniplestim, binds to the IL-3 receptor-α subunit with 60-fold greater affinity and induces cell proliferation and colony-forming unit formation 10- to 22-fold better than native IL-3. A chimeric cytokine, myelopoietin-1, composed of daniplestim and a G-CSF receptor agonist binds both the IL-3 and G-CSF receptors. While the in vivo effects of daniplestim and myelopoietin-1 are well described, the mechanisms by which they stimulate growth are not well understood. We have investigated the effects of daniplestim and myelopoietin-1 on the prevention of apoptosis in two human hematopoietic cell lines, OCI-AML.5 and AML 193. Daniplestim and myelopoietin-1 prevented apoptosis to a greater degree than native recombinant IL-3 or G-CSF as determined by annexin V/propidium iodide binding and TUNEL assays. Daniplestim and myelopoietin-1 promoted the maintenance of the mitochondrial membrane potential better than native IL-3 or G-CSF. These cytokines promoted a lower redox potential as higher levels of free radicals were detected after cytokine treatment than in cytokine-deprived cells implying increased respiration. These results indicate that daniplestim and myelopoietin-1 are able to prevent apoptosis in hematopoietic cells more effectively than native IL-3 and G-CSF. These effects of daniplestim and myelopoietin-1 may contribute to their effective ability to repopulate hematopoietic precursor cells after chemotherapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  1. Blalock WL, Weinstein-Oppenheimer C, Chang F, Hoyle PE, Wang XY, Algate PA, Franklin RA, Oberhaus SM, Steelman LS, McCubrey JA . Signal transduction, cell cycle regulatory and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs Leukemia 1999 13: 1109–1166

    Article  CAS  Google Scholar 

  2. Weinstein-Oppenheimer CR, Blalock WL, Steelman LS, Chang F, McCubrey JA . The Raf signal transduction cascade as a target for chemotherapeutic intervention in growth factor-responsive tumors Pharmacol Ther 2000 88: 229–279

    Article  CAS  Google Scholar 

  3. Creagh EM, Sheehan D, Cotter TG . Heat shock proteins – modulators of apoptosis in tumour cells Leukemia 2000 14: 1161–1173

    Article  CAS  Google Scholar 

  4. Blagosklonny MV . Cell death beyond apoptosis Leukemia 2000 14: 1502–1508

    Article  CAS  Google Scholar 

  5. White MK, McCubrey JA . Suppression of apoptosis: role in cell growth and neoplasia Leukemia 2001 15: (in press)

    Article  Google Scholar 

  6. Blagosklonny MV . Drug-resistance enables selective killing of resistant leukemia cells: exploiting of drug resistance instead of reversal Leukemia 1999 13: 2031–2035

    Article  CAS  Google Scholar 

  7. Schwartzman RA, Cidlowski JA . Apoptosis: the biochemistry and molecular biology of programmed cell death Endocrine Rev 1993 14: 133–151

    CAS  Google Scholar 

  8. Arrends M, Wyllie A . Apoptosis: mechanisms and roles in pathology Int Rev Expl Path 1991 32: 223–251

    Article  Google Scholar 

  9. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM . Exposure of phosphatidyl serine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages J Immunol 1992 148: 2207–2216

    CAS  Google Scholar 

  10. McCubrey JA, May WS, Duronio V, Mufson A . Serine/threonine phosphorylation in cytokine signal transduction Leukemia 2000 14: 9–21

    Article  CAS  Google Scholar 

  11. Kinoshita T, Yokata T, Arai K, Miyajima A . Suppression of apoptotic death in hematopoietic cells by signalling through the IL-3/GM-CSF receptors EMBO J 1995 14: 265–275

    Article  Google Scholar 

  12. Nûnez G, London L, Hockenbery D, Alexander M, McKearn JP, Korsmeyer SJ . Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines J Immunol 1990 144: 3602–3610

    PubMed  Google Scholar 

  13. Blagosklonny MV, Churman Y, Bergan RC, Fojo T . Mitogen-activated protein kinase pathway is dispensable for microtubule-active drug-induced Raf-1/Bcl-2 phosphorylation and apoptosis in leukemic cells Leukemia 2000 14: 1028–1036

    Google Scholar 

  14. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ . Serine phosphorylation of death agonist Bad in response to survival factor results in binding to 14–3-3 not Bcl-xL Cell 1996 87: 619–628

    Article  CAS  Google Scholar 

  15. Franklin RA, McCubrey JA . Kinases: positive and negative regulators of apoptosis Leukemia 2000 14: 2019–2034

    Article  CAS  Google Scholar 

  16. del Peso L, Gonzalez-Garcia M, Page C, Herrera R, Nunez G . Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt Science 1997 278: 687–689

    Article  CAS  Google Scholar 

  17. Farese AM, Herodin F, McKearn JP, Baum C, Burton E, MacVittie TJ . Acceleration of hematopoietic reconstitution with a synthetic cytokine (SC-55494) after radiation-induced bone marrow aplasia Blood 1996 87: 581–591

    CAS  PubMed  Google Scholar 

  18. Olins PO, Bauer CS, Bradford-Goldberg S, Sterbenz K, Polazzi JO, Caparon MH, Klein BK, Easton AM, Paik K, Klover JA, Thiele BR, McKearn JP . Saturation mutagenesis of human interleukin-3 J Biol Chem 1995 270: 23754–23760

    Article  CAS  Google Scholar 

  19. Thomas JW, Baum CM, Hood WF, Klein B, Monahan JB, Paik K, Staten N, Abrams M, McKearn JP . Potent interleukin 3 receptor agonist with selectively enhanced hematopoietic activity relative to recombinant human interleukin 3 Proc Natl Acad Sci USA 1995 92: 3779–3783

    Article  CAS  Google Scholar 

  20. Klein BK, Feng Y, McWherter CA, Hood WF, Paik K, McKearn JP . The receptor binding site of human interleukin-3 defined by mutagenesis and molecular modeling J Biol Chem 1997 272: 22630–22641

    Article  CAS  Google Scholar 

  21. Merlin S, Rowold E, Abeegg A, Berlund C, Klover J, Staten N, McKearn JP, Lee SC . Phage presentation and affinity selection of a deletion mutant of human interleukin-3 Appl Biochem Biotech 1997 67: 199–214

    Article  CAS  Google Scholar 

  22. Feng Y, Hood WF, Forgey RW, Abegg AL, Caparon MH, Thiele BR, Leimgruber RM, McWherter CA . Multiple conformations of a human interleukin-3 variant Prot Sci 1997 6: 1777–1782

    Article  CAS  Google Scholar 

  23. Fleming WH, Lankford-Turner P, Turner CW, Wong J, Storbert E, McKearn JP . Administration of daniplestim and granulocytecolony-stimulating factor for the mobilization of hematopoieticprogenitor cells in nonhuman primates Biol Blood MarrowTransplant 1999 5: 8–14

    Article  CAS  Google Scholar 

  24. MacVittie TJ, Farese AM, Heodin F, Grab LB, Baum CM, McKearn JP . Combination therapy for radiation-induced bone marrow aplasia in nonhuman primates using synthokine SC-55494 and recombinant human granulocyte colony-stimulating factor Blood 1996 87: 4129–4135

    CAS  PubMed  Google Scholar 

  25. McWherter CA, Feng Y, Zurfluh LL, Klein BK, Baganoff MP, Polazzi JO, Hood WF, Paik K, Abegg AL, Grabbe ES, Shieh JJ, Donnelly AM, McKearn JP . Circular permutation of the granulocyte colony-stimulating factor receptor agonist domain of myelopoietin Biochemistry 1999 38: 4564–4571

    Article  CAS  Google Scholar 

  26. Feng Y, Minnerly JC, Zurfluh LL, Joy WD, Hood WF, Abegg AL, Grabbe ES, Shieh JJ, Thurman TL, McKearn JP, McWherter CA . Circular permutation of granulocyte colony-stimulating factor Biochemistry 1999 38: 4553–4563

    Article  CAS  Google Scholar 

  27. MacVittie TJ, Farese AM, Davis TA, Lind LB, McKearn JP . Myelopoietin, a chimeric agonist of human interleukin 3 and granulocyte colony-stimulating factor receptors, mobilizes CD34+ cells that rapidly engraft lethally x-irradiated nonhuman primates Exp Hematol 1999 27: 1557–1568

    Article  CAS  Google Scholar 

  28. Drexler HG . Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells Leukemia 1996 10: 588–599

    CAS  PubMed  Google Scholar 

  29. Steelman LS, Algate PA, Blalock WL, Wang XY, Prevost KD, Hoyle PE, McCubrey JA . Oncogenic effects of overexpression of the interleukin-3 receptor on hematopoietic cells Leukemia 1996 10: 528–542

    CAS  PubMed  Google Scholar 

  30. Wang XY, McCubrey JA . Differential effects of retroviral long terminal repeats on interleukin-3 gene expression and autocrine transformation Leukemia 1997 11: 1711–1725

    Article  CAS  Google Scholar 

  31. Wang X-Y, McCubrey JA . Characterization of proteins binding specifically to the interleukin 3 (IL-3) mRNA 3′ untranslated region in IL-3-dependent and autocrine transformed cells Leukemia 1998 12: 520–531

    Article  CAS  Google Scholar 

  32. Moye PW, Blalock WL, Hoyle PE, Chang F, Franklin RA, Weinstein-Oppenheimer R, Pearce M, Steelman LS, McMahon M, McCubrey JA . Synergy between Raf and BCL2 in abrogating the cytokine-dependency of hematopoietic cells Leukemia 2000 14: 1060–1079

    Article  CAS  Google Scholar 

  33. McCubrey JA, Steelman LS, Hoyle PE, Blalock WL, Weinstein-Oppenheimer C, Franklin RA, Cherwinski H, Bosch E, McMahon M . Differential abilities of activated Raf oncoproteins to abrogate cytokine-dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells Leukemia 1998 12: 1903–1929

    Article  CAS  Google Scholar 

  34. Weinstein-Oppenheimer C, Steelman LS, Algate PA, Blalock WL, Shelton JL, Moye PW, Hoyle PE, Lee JT, Franklin RA, McCubrey JA . Effects of deregulated Raf activation on integrin and cytokine-receptor expression and the induction of apoptosis in hematopoietic cells Leukemia 2000 14: 1921–1939

    Article  CAS  Google Scholar 

  35. Frankel AE, McCubrey JA, Miller MS, Delatte S, Ramage J, Kiser M, Kucera GL, Alexander RL, Beran M, Tagge EP, Kreitman RJ, Hogge DE . Diptheria toxin fused to human interleukin-3 is toxic to blasts from patients with myeloid leukemias Leukemia 2000 14: 576–585

    Article  CAS  Google Scholar 

  36. Blalock WL, Moye PW, Chang F, Pearce M, Steelman LS, McMahon M, McCubrey JA . Combined effects of aberrant MEK1 activity and BCL2 overexpression on relieving the cytokine-dependency of human and murine hematopoietic cells Leukemia 2000 14: 1080–1096

    Article  CAS  Google Scholar 

  37. Hoyle PE, Moye PW, Steelman LS, Blalock WL, Franklin RA, Pearce M, Cherwinski H, Bosch E, McMahon M, McCubrey JA . Differential abilities of the Raf family of protein kinases to abrogate cytokine-dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism Leukemia 2000 14: 642–656

    Article  CAS  Google Scholar 

  38. Douer D, Ramezani L, Parker J, Levine AM . All-trans retinoic acid affects the growth, differentiation and apoptosis of normal human myeloid progenitors derived from purified CD34+ bone marrow cells Leukemia 2000 14: 874–881

    Article  CAS  Google Scholar 

  39. Peters R, Leyvraz S, Perey L . Apoptotic regulation in primitive hematopoietic precursors Blood 1998 92: 2041–2052

    CAS  PubMed  Google Scholar 

  40. Blalock WL, Pearce M, Chang F et al. Effects of inducible MEK1 activation on the cytokine dependency of lymphoid cells Leukemia 2001 15: 794–807

    Article  CAS  Google Scholar 

  41. Haseyama Y, Sawada Ki, Oda A, Koizumi K, Takano H, Tarumi T, Nishio M, Handa M, Ikeda Y, Koike T . Phosphatidylinositol 3-kinase is involved in the protection of primary cultured human erythroid precursor cells from apoptosis Blood 1999 94: 1568–1577

    CAS  PubMed  Google Scholar 

  42. Furuke K, Sasada T, Ueda-Taniguchi Y, Yamauchi A, Inamoto T, Yamaoka Y, Masutani H, Yodoi J . Role of intracellular redox status in apoptosis induction of human T-cell leukemia virus type 1-infected lymphocytes by 13-cis-retinoic acid Cancer Res 1997 57: 4916–4923

    CAS  PubMed  Google Scholar 

  43. Choi CH, Ling V . Isolation and characterization of daunorubicin-resistant AML-2 sublines Mol Cells 1997 7: 170–177

    CAS  PubMed  Google Scholar 

  44. Monahan JB, Hood WF, Joy WD, Caparon MH, Bradford-Goldberg S, Klein BK, Staten NR, Pegg LE, Bauer SC, Mina MS, Hirsch JL, Giri JG, McKearn JP . Receptor binding and signaling characteristics of MPO-1 (SC-68420) – multifunctional IL-3 and G-CSF receptor agonist Exp Hematol 1996 24: 714a

    Google Scholar 

  45. Madrid LV, Wang CY, Guttridge DC, Schottelius AJ, Baldwin AS Jr, Mayo MW . Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB Mol Cell Biol 2000 20: 1626–1638

    Article  CAS  Google Scholar 

  46. Hong SY, Yoon WH, Park JH, Kang SG, Ahn JH, Lee TH . Involvement of two NF-kappa B binding elements in tumor necrosis factor alpha-, CD40−, and Epstein–Barr virus latent membrane protein 1-mediated induction of the cellular inhibitor of apoptosis protein 2 gene J B Chem 2000 275: 18022–18028

    Article  CAS  Google Scholar 

  47. Janes PW, Ley SC, Magee AI . Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor J Cell Biol 1999 147: 447–461

    Article  CAS  Google Scholar 

  48. Brown DA, London E . Functions of lipid rafts in biological membranes Ann Rev Cell Dev Biol 1998 14: 111–136

    Article  CAS  Google Scholar 

  49. Simons K, Ikonen E . Functional rafts in cell membranes Nature 1997 387: 569–572

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

McCubrey, J., Blalock, W., Saleh, O. et al. Enhanced ability of daniplestim and myelopoietin-1 to suppress apoptosis in human hematopoietic cells. Leukemia 15, 1203–1216 (2001). https://doi.org/10.1038/sj.leu.2402167

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402167

Keywords

This article is cited by

Search

Quick links